Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist. (2024)

First Author: Balikçi E
Attributed to:  ADP-ribosylation of DNA in Mycobacterium tuberculosis funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.4c00072

PubMed Identifier: 38635563

Publication URI: http://europepmc.org/abstract/MED/38635563

Type: Journal Article/Review

Volume: 67

Parent Publication: Journal of medicinal chemistry

Issue: 9

ISSN: 0022-2623